Researchers found that a new oral solution called Tessie® has been approved by the U.S. Food and Drug Administration (FDA) for treating noise aversion and separation anxiety in dogs. This innovative treatment, developed by Orion Corporation, aims to help dogs who experience stress from loud noises or being left alone, making life easier for both pets and their owners.

This approval is significant for pet owners who want to improve their dogs’ quality of life. Dogs suffering from noise aversion may panic during thunderstorms or fireworks, while those with separation anxiety can become destructive or excessively vocal when left alone. With Tessie®, pet owners could see a reduction in these distressing behaviors, leading to a calmer, happier pet and a more peaceful home environment.

The evidence supporting Tessie® comes from its development as a proprietary molecule by Orion, but it is important to note that the specific clinical data on its effectiveness and safety in dogs has not been detailed in this announcement. While the approval is a step forward, pet owners should approach this new treatment with cautious optimism until more information is available about its performance in real-world scenarios. Tessie® is expected to be available in the U.S. by mid-2027, marketed exclusively by Zoetis, a leading animal health company.

For pet owners, it may be beneficial to stay informed about Tessie® and discuss its potential use with a veterinarian when it becomes available, particularly if their dog shows signs of anxiety or stress.

Source: globenewswire.com